DSC
EVGN icon

Daytona Street Capital’s Evogene EVGN Stock Holding History

Daytona Street Capital’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.65K Sell
9,253
-333
-3% -$231 ﹤0.01% 256
2026
Q1 		$7.7K Hold
9,586
– – 0.01% 260
2025
Q4 		$10.5K Buy
+9,586
New +$11.2K 0.01% 262

Other funds holding EVGN

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Daytona Street Capital's EVGN Position: Q2 2026 in Review

Daytona Street Capital reduced its Evogene (EVGN) stake by 3.5% in Q2 2026, selling an estimated $231 and leaving 9,253 shares worth $4.65K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

Daytona Street Capital first reported a position in EVGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.5K in Q4 2025. 2 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.

  • Daytona Street Capital held 9,253 shares of Evogene worth $4.65K as of Q2 2026.
  • Daytona Street Capital sold 333 Evogene shares in Q2 2026, an estimated $231.
  • Evogene made up ﹤0.01% of Daytona Street Capital's portfolio in Q2 2026, its #256 holding.
  • Daytona Street Capital first reported a position in Evogene in Q4 2025 and has held it in 3 quarters since.
  • Daytona Street Capital's Evogene position peaked at $10.5K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.